At Home with and : Human-Rodent Interactions and Potential for Primary Transmission of Lassa Virus in Domestic Spaces
Overview
Authors
Affiliations
AbstractThe multimammate mouse () is the reservoir for Lassa virus (LASV). Zoonotic transmission occurs when humans are directly or indirectly exposed to fluids of the multimammate mouse, such as urine, saliva, and blood. Housing characteristics and domestic organization affect rodent density in and around households and villages, and are likely to be a risk factor for Lassa fever in humans where the reservoir exists. We use semi-structured interviews ( = 51), a quantitative survey ( = 429), direct observations, and a rodent ecology study to provide new insights into how the organization of domestic spaces brings together humans and rodents and creates pathways for infection in rural settlements in Bo District, Sierra Leone. Rodents were frequently reported inside houses (92.4% of respondents), in which we predominantly trapped (57% of trapped rodents) and (38% of trapped rodents). Building design and materials provide hiding and nesting places for rodents and lead to close proximity with humans. Patterns of contact are both unintentional and intentional and research participants reported high levels of contact with rodents (34.2% of respondents) and rodent fluids (52.8% of respondents). Rodents are also perceived as a serious threat to food security. These results present detailed knowledge about how humans live with and come into contact with rodents, including the LASV reservoir. Our results argue for further collaborative research in housing and environmental modification such as ceiling construction, food storage, and sanitation as prevention against zoonotic LASV transmission.
Kolo A, Brayton K, Collins N, Bastos A, Matthee S, Gall C Front Cell Infect Microbiol. 2025; 15:1520086.
PMID: 39963409 PMC: 11830667. DOI: 10.3389/fcimb.2025.1520086.
Identifying risk factors for clinical Lassa fever in Sierra Leone, 2019-2021.
Sama D, Haider N, Guitian J, Osman A, Ntoumi F, Zumla A Epidemiol Infect. 2024; 152:e177.
PMID: 39562292 PMC: 11696580. DOI: 10.1017/S095026882400164X.
A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs.
Carey B, Yu S, Geiger J, Ye C, Huzella L, Reeder R NPJ Vaccines. 2024; 9(1):220.
PMID: 39551823 PMC: 11570604. DOI: 10.1038/s41541-024-01012-w.
Double stigma: a cross-sectional study of Lassa patients with hearing loss in North Central Nigeria.
Best K, Ameh E, Weldon C, Shwe D, Maigari I, Turaki I Front Public Health. 2024; 12:1395939.
PMID: 39076422 PMC: 11284147. DOI: 10.3389/fpubh.2024.1395939.
Kamara A, Moseray A, Fatoma P, Mayei A, Lamin J, Sankoh O BMC Public Health. 2024; 24(1):1684.
PMID: 38914994 PMC: 11197251. DOI: 10.1186/s12889-024-19170-w.